N
Google TrendCHAMPIONS LEAGUE SCHEDULE (500+) — Champions League Matchday 2: Key stats and what to look out for in every game
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:champions league schedule500+matthew stone sr500+geomagnetic storm aurora visibility northern us500+selma blair5000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Disproportionality analys" (30 stories)

Top Headline Story

Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Lead StoryThe Cureus Journal of Medical Sciencegeneral
May 14

Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System

<a href="https://news.google.com/rss/articles/CBMiqgJBVV95cUxNMktwekJha1VsbFZ1Y0tZbW1SNEhHdmVUM0ZfVTVzX0o3V1NPLVdLWGxZZDNHUWVaUW5MM0trcG8wS2hyTm1Jd01KX1VUS0RYUVNWdlo0MkJTTEVrLThfNU4wMEFkQWliV2xxWWNxZnVDNHh4TU5WUUxuZDdhaUN1TXJYTHpEWWkzbU9Bcm11YjdOUEdlbVFNZ1c1T1NZSUdZVnB3bm5uRmZrNDdZTHY1bEw2ZExXdnZBaUw0ZWpocUtjbXU4Rnpqc0stNF9NTXpKYkt1RFE3SXBMdjhoSEJlcjFXOGFkd2c1Y2JtWXEyUm1uakR3MFV5UHVFU0VTYk11QUlYTHFPVmdwa2t6eU9RY09MTEQ3NlFYbC02dTFnTklEUzE2NmtJelVB?oc=5" target="_blank">Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+16m ago

champions league schedule

Champions League Matchday 2: Key stats and what to look out for in every game

Filter stories
500+26m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
500+26m ago

geomagnetic storm aurora visibility northern us

Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday

Filter stories
5000+46m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Filter stories

Search Results for "Disproportionality analys"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
A real-world, population-based disproportionality analysis of glaucoma and cataracts attributed to steroids
Natureworld

A real-world, population-based disproportionality analysis of glaucoma and cataracts attributed to steroids

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qZ3ZiQ1I4RDhMV19kVnlEUS1mbUFCWnV3a2JtaWoyMGNSQTUzTHlibzIwc0duYm5PZGFONUlVVlFSelZ5bE93elBFMjFCQWxteWlBRmk0dzRTTXZxZGI4?oc=5" target="_blank">A real-world, population-based disproportionality analysis of glaucoma and cataracts attributed to steroids</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis
Springer Nature Linkgeneral

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5sVDhFUVFaT2lySUZFMWlweWRpMU91ODAteWoyNG1QY1dESDc3TmRaMnNydnEycEY1ZXVNZkJuVGsyN2NRY190cDBzNEJrNGJUWF9NaUUxYjh1N0xUOTZiWjR5Ung4S0VvUFZiNQ?oc=5" target="_blank">The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
Lu]Lu-DOTATATE safety: a comprehensive disproportionality analysis from the WHO pharmacovigilance database
Naturegeneral

Lu]Lu-DOTATATE safety: a comprehensive disproportionality analysis from the WHO pharmacovigilance database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9QM0duMFJyYm50UzkzM3A3TjhhSXdWYjB2WE5BZ0J0MTJpX2lWeGZfdGZGOHpPbFQ1eTcxMWdzaHJ1UWpUT1FLZndHbU5OQWJMS1pLX2JoM0Z1em1qY21Z?oc=5" target="_blank">Lu]Lu-DOTATATE safety: a comprehensive disproportionality analysis from the WHO pharmacovigilance database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab
Frontiersworld

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQRFRNTllXMGplV1c2NVVMTGtobVBMQk94MFFvcEZ3bGhBX0duUVkydEJpTFpkMnNKZll3cGw2OW43eU1yYkJad2xMTGREM3VuSEZwVFA0YURqMVFZS3I0Q0Y5NEgwTksyYkpJWEtKVUxkSVJVeFdFdDVlTHA3STAzT0NaNWJsU3gwTlk1ODIyTl91WU90?oc=5" target="_blank">A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis
Naturegeneral

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5mVFN3THlvRjl5ZE9wQXBLbmtSNXRSS2VUVjVHUHVnRFAwc3lFOW9iTHZWUW1td1JmMFZ1WGNHWUoxMjZiVTJWMnA2bGVqNHlSQUZwSkVoQW5sZjNQemRV?oc=5" target="_blank">Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Drug-induced agranulocytosis: a disproportionality analysis and umbrella review
Frontiersgeneral

Drug-induced agranulocytosis: a disproportionality analysis and umbrella review

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQYm1GRTI5bXhnTExkeVVZU04yU1ZOVkN0eko4R0s2TVV2VHpBQml0NDFCVDBEYUtHc1Zsc2dVN0FpRVBVVm1jYWI0ajgxVWFaYjdTVVlna3dLdDI5T0Frd3JnX3RvSklJbWRreWt5bmlsNXUtZXZ1S0ExZS11QmRKRm1Hc1k1SkFCa2ZyZV9fbFZVR1By?oc=5" target="_blank">Drug-induced agranulocytosis: a disproportionality analysis and umbrella review</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
Naturegeneral

Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sS3h3YzVESXRHNmp1dFVFcURmQUxiRmFxSUJZT3NHaUxuX0lGVWllZmVaWkczUTdwd0Z1QTZOQVMyblhmMUFRTmRZenpFbDV1QmxrSmtFX0xOWEdSc19j?oc=5" target="_blank">Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
Frontiersgeneral

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPTzlpY2tBTUtZVjdnUmVJbmRBWll2REdtdXoyRmhnUVhqSTNKVDJNVDNsQkdUb0Q3Szd3VGVlSGYyakNDS2RCUDlVYXNpWHRFTEVucmRPR19WUmlWMEZpWHZ2TXh1aXU1YzZtS2s4MDZ1ZWotR0hEaGxNbThBUGV5S3hqeEtKaWlBSi16dGQtdWhoOFJz?oc=5" target="_blank">The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024 | Scientific Reports
Naturegeneral

A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024 | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE13T29MZHloYTFpSERSaXRWNm5mWEVKcmFXTmdsUmowYzRSWXhlV2FhT2FKUk5GX1NGcnRXRTEwcHdlQ1BlNmduWEg2N19LR0EzV3pkMmlNczdzMktiMncw?oc=5" target="_blank">A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024 | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Disproportionality analysis of drug-induced erectile dysfunction using FAERS database
Natureworld

Disproportionality analysis of drug-induced erectile dysfunction using FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1fbHlsQXZadFgzM19RaXhEVmFrZTIxZU40enl2RHBzRXA4Wk5naGVuV2doc1hRQndtMlFqT2NLNkFGTjlRbFdWeFl1RUdCSVpJR29hZ1hMTG9fMGxHRUhz?oc=5" target="_blank">Disproportionality analysis of drug-induced erectile dysfunction using FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Disproportionality analysis of infection associated with antidiabetic drug use patterns
Naturegeneral

Disproportionality analysis of infection associated with antidiabetic drug use patterns

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BMUIzV2hOc2x0RUlQdllRbWJNRnQ3Vm41NTZKVm1rS1kybzFGeXhxdHFKUzRKR1dhWkRwVFF5cWJMZVY3dDdDcW41a2xGY01YNENZdEFZbTVXVkVyX0M4?oc=5" target="_blank">Disproportionality analysis of infection associated with antidiabetic drug use patterns</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
Naturegeneral

A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE10ZjRXUXNIVzlKOVhzU0hkRDNRTHdZd3dCVVh0YzVfY0JOT3A1bnRHdHFMZ2JMQWlTX2l0YWRUWHFNUUJFM1ZXSEJ4TVc4WWxIVE9yRGc1Rl9ETWRxcURj?oc=5" target="_blank">A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database
Naturegeneral

Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IX0RVanlRczZSTDlQb2xUeUZyc25GeGV4Ul9wd2tjTjM4NnplQjlHMlNxRW5McVBISHdnanZZbC1yWW5CaDJoN3FCMTRoaGQ1M2YxQllveVRJbkJvTms4?oc=5" target="_blank">Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database
Natureworld

A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB1Yl84R1dGdXV2a184Q0V2cVg0LW1vRUtvbnFBN3JsZ3Jtcm9vYVAtZjRYc21pS2NLU3BYN1drc0tfdUhhR3NZWDd2b0k2UGtxU0kzLXk3T1I5U2VFOHhN?oc=5" target="_blank">A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury
Naturegeneral

FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5uOHBPWUlJM0ExNExDX3N3QnhSejFYRTUwSklzSEpkc2swbEJIY2pLMVJ0blZHVXRrRExyVUNJMlBZeC1lMjJsd0I3YmlKN0FfeGNzY2RPMTVPSVluTXF3?oc=5" target="_blank">FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Subgroup disproportionality analysis of dementia-related adverse events with sacubitril/valsartan across geographical regions
Naturegeneral

Subgroup disproportionality analysis of dementia-related adverse events with sacubitril/valsartan across geographical regions

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5waERuZDFqWTk3WXBaOG1IS2IxVVFmbWdTRS1ldUJnWU1yLWYwOTFfZ25zMVRSRWJiQkJvdDBUVVZoSVU3cDBWMXhpcHBUdFhHZmZVNW8zcHE2N0hhZzVj?oc=5" target="_blank">Subgroup disproportionality analysis of dementia-related adverse events with sacubitril/valsartan across geographical regions</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system
Naturemarkets

Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GVFdDdXgzTjE0SUJlOGtybUxCdVh0U1EwMXlGcTVFLUhLa0NURkVfVlhxVkdfeXlYZklSalI4TUd5dkU4VjZUd0E2RTFQVGpwQnZ3MTAwaWlXaU9BLWow?oc=5" target="_blank">Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination
Natureworld

Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BbWQwa3JjaHpGS2pnb3prenZ5d3ZHXzhCYmhiWnB5OF9QUGxzcHlSQUhJVXFDbEVocE9tWlVDakRLNzhvZXpxVFpfdkRXd2MwbGl5LUhMbE5DZllmRjI4?oc=5" target="_blank">Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
FAERS based disproportionality analysis and network pharmacology investigation of doxorubicin associated drug induced cardiotoxicity
Naturegeneral

FAERS based disproportionality analysis and network pharmacology investigation of doxorubicin associated drug induced cardiotoxicity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBSUFlqNklhSV9OYUoway1lS1BEZmlxSTZPT1NHa3NQSXRJMGJEY19BUk5VOS1JLVpMbGtpM3drZ0Q0QTdMa3BIRnFlRHJxWXJwUzNYbkozQ1RCbGpQTDhN?oc=5" target="_blank">FAERS based disproportionality analysis and network pharmacology investigation of doxorubicin associated drug induced cardiotoxicity</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
Natureworld

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BLUJvM3EyeDZOUkg2ZDdZamdUeFNROHV1b2ZuTy1jWlhHdURRSV9aamZ3UktKTHZ1MHlSWkhITUk5UTR6VUhqNndPR0syQ0hZUHo1ZW40eUxCZU4wOE9J?oc=5" target="_blank">A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action
Frontiersgeneral

Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQYXFUQ3h6R2FsSVgzWUMyZkk3NlJqRUxZemkxRXIweE1SV3pDWmNQMldWaGJJMktDMl90N2pzNzVrVkVmOXFMMWplTExuWThTVWZ1RjA3QkNJWDNyR09SSnIzZjZsRXVFMzdoeEYxS1RWM1IwNmRabFhtTlY0Zl9SRHRPM1ZMY1V4ZGxUb3liRWNEUEE5?oc=5" target="_blank">Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Signal detection of adverse events in medical devices using natural language processing: a case study in pelvic mesh
Naturegeneral

Signal detection of adverse events in medical devices using natural language processing: a case study in pelvic mesh

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqMFBKOXZfOXpvcGVTVEQxTzEtZ2VDVHRQUWxoU2JRSWlsSUV1VWZpOXhiZGdUbUVlZWFmWHR3TnlBNENsS1NhOVJzU2FVNUVhZE1FMFFMcE5KYmZOcHo4?oc=5" target="_blank">Signal detection of adverse events in medical devices using natural language processing: a case study in pelvic mesh</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials
Naturegeneral

Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1faDZkRVlQcURzYm0zY2xhTHRnd3JCYndjN0NZNF9heWd5cWpWSEMxY0oyTGdzamRpbEh5MWlucC1IdUxkb3BaTUptU3ZVanBLN1BpVV9zOU1VTU5jV1pz?oc=5" target="_blank">Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system
Natureworld

Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5Yb0ZTLWpNUm5yVWR1M2t3amE3Qm9GM1g0a0o5R1o4WHNIUTctRmJpWGtpR2plbXN4emdDbW9tTDFNQTdOYlJtcXdmbmh3eUxoOWlHNEVoU1NfaHl3Y1JN?oc=5" target="_blank">Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Comparison of safety of lecanemab and donanemab: a real-world disproportionality analysis using the FDA adverse event reporting system
Frontiersworld

Comparison of safety of lecanemab and donanemab: a real-world disproportionality analysis using the FDA adverse event reporting system

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQZzF6NWY0TWdiQlRYSkJyYUhrN0tkejFKM1d4aEJQbkNWMHNZcU5uMXRhWFVLUUxzR3ZzUEFrbGh5RjZyLVhmSUwxdFgzZENzemd3dWFVYWVyazJoNzlsWGxGeV9wTV8zUVlwM3UtZzhtLVBDRU9vT2c3aU1SZFFXS3ZQQzQ4VmdkUXdiall6SERFX0dL?oc=5" target="_blank">Comparison of safety of lecanemab and donanemab: a real-world disproportionality analysis using the FDA adverse event reporting system</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Drug-induced hearing disorders: a disproportionality analysis of the FAERS database
Frontiersgeneral

Drug-induced hearing disorders: a disproportionality analysis of the FAERS database

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOZERIWVhtbXZQWnVOVnE4TTNaX0xHNGdlUVZ5X3BmMEZNRHpmOEx4WWRZWVBRSFZENlc1Q3FISG5zdDlVLXBvZk5acFR5aEVSZVFvQ3otTUJqZTdMa19wcm52WVVKTEtKTGVlLUwzS1ZTdmhBZlJXV01PQ2VUR2lhaDE2bUxHZXNpdUcxSjJzN3ItanQt?oc=5" target="_blank">Drug-induced hearing disorders: a disproportionality analysis of the FAERS database</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis
Frontiersgeneral

Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNY0QwakNrWnRTWlZRNzFvcm5iYi0xVlJJeEJjSHM5eU13b21VZ3RqbzZKWlJKdGhMZlBvdTZlVllPMFhnRDdBcWtJSFJLNHY1dkFoc3JlZ2Y3b19qMGFsd0ozWUhVVm5BWGpxTmx4U2N4Zmh6OHM1X0NTMmQwRmRfNWdhY0RmYjdGek40YjJtbGhEUDkz?oc=5" target="_blank">Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
Natureworld

A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBacU1BeGc3aWhmeEI3Y1JiX0laYWhNaFE5MHh1cVpFUGNQMXpOd0hfOHVUakNzQ0l6VDUyelNiS2Zib25ydVlON3RSazhlZVY3TDFkMDJ6TEVuNUhjOWEw?oc=5" target="_blank">A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database
Naturegeneral

A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5iRDVrM3F6VndadVZVRXVHcmRvRW9jOFUyNmJQZTVsLUFBbmNYcGdTVk40S21tWHdpNTFKZEpPaGQxTmxQZTZnVm14djNsUWM4N0NtUUVnRFVsM1dvRjlN?oc=5" target="_blank">A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"Disproportionality analys" — Live Google News Trends & Headlines